According to Stat News, the partial government shutdown in the US could soon affect the ability of the Food and Drug Administration to review new drugs.
Data from the GUIDED study will be central to commercial payor discussions, a Medicare LCD reconsideration request, and eventually expansion into the primary care market.
Sequencing has helped identify where an E. coli outbreak may have originated, the Atlanta Journal-Constitution reports.
The partial federal government shutdown in the US affects a number of science agencies, ScienceInsider reports.
The test is the second of three panels intended to detect pathogens that cause the bloodstream infections that can lead to sepsis.
New drugs, tests, and policies suggest steady and continued future growth in the space, though public awareness of personalized medicine continues to lag.
The firm had also applied for marketing clearance for its gram negative and fungal pathogen panels in October.
The test is now approved as a CDx for advanced ovarian cancer patients considering Lynparza as a first-line maintenance treatment.
A partial US government shutdown would affect scientific research, Nature News says.
The Washington Post reports on uncertainties facing gene-edited livestock endeavors.
University of Idaho researchers model the scientific discovery process to examine the link between reproducibility and scientific truth.
A bill passed by a US House of Representatives appropriations subcommittee would give scientific agencies including the National Science Foundation boosts in funding.
Relocating USDA agencies outside of Washington, DC, may make them less effective, critics of the move tell NPR.
In PLOS this week: genes that help Borrelia burgdorferi survive in ticks, CiliaCarta collection of about 1,000 suspected cilia genes, and more.